Tryptophan Fluorescence Quenching by Enzyme Inhibitors As a Tool for Enzyme Active Site Structure Investigation: Epoxide Hydrolase

被引:19
|
作者
Matveeva, Evgenia G. [1 ]
Morisseau, Christophe [2 ]
Goodrow, Marvin H. [2 ]
Mullin, Chris [3 ]
Hammock, Bruce D. [2 ]
机构
[1] Univ N Texas, Hlth Sci Ctr, Ctr Commercializat Fluorescence Technol, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA
[2] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA
[3] Penn State Univ, Pesticide Res Lab, Dept Entomol, University Pk, PA 16802 USA
关键词
Soluble epoxide hydrolase; tryptophan fluorescence quenching; enzyme inhibitors; inhibitor detection; UREA; MURINE; LIVER; ACTIVATION; EXPRESSION; CLONING; ROLES; QSAR;
D O I
10.2174/138920109789069260
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We present the strong fluorescence effect, a new 392 nm emission peak appearing after binding of a naphtol-urea inhibitor XIIa to the enzyme epoxide hydrolase (EH), along with the quenching of the EH tryptophan fluorescence. We have studied the quenching of the 392-nm peak (attributed to XIIa bound inside the active center of the enzyme) of the mixture EH+XIIa by various strong transparent inhibitors (competing with XIIa for binding to EH), and measured the corresponding values of the Stern-Volmer constants, K(mix)(SV). Strong EH inhibitors demonstrate different replacement behavior which can be used to distinguish them. We further demonstrate a novel fluorescent assay which allows to distinguish highly potent inhibitors and to visualize the strongest among them. We generated our assay calibration curve based on the quenching data, by plotting quenching strength K(mix)(SV) versus inhibiting strength, IC(50) values. We used moderate inhibitors for the assay plot generation. We then applied this curve to determine IC(50) values for several highly potent inhibitors, with IC(50) values at the limit of the IC(50) detection sensitivity by colorimetric enzyme assay. IC(50) values determined from our quenching assay show correlation with IC(50) values determined in the literature by more sensitive radioactive-based assay and allow differentiating the inhibitors potency in this group. To our knowledge, this is the first inhibitor assay of such kind. Chemical inhibition of EH is an important technology in the treatment of various cardiovascular diseases, therefore, this tool may play a crucial role in discovering new inhibitor structures for therapeutic EH inhibition.
引用
收藏
页码:589 / 599
页数:11
相关论文
共 7 条
  • [1] DESIGN, ADMET AND DOCKING STUDIES ON SOME NOVEL CHALCONE DERIVATIVES AS SOLUBLE EPOXIDE HYDROLASE ENZYME INHIBITORS
    Asokkumar, Kuppusamy
    Prathyusha, Lokeswari Tangella
    Umamaheshwari, Muthusamy
    Sivashanmugam, Thirumalaisamy
    Subhadradevi, Varadharajan
    Jagannath, Puliyath
    Madeswaran, Arumugam
    Salesheir, Francis
    JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2012, 57 (04): : 1442 - 1446
  • [2] Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase
    Chen, Hang
    Zhang, Ying
    Ye, Chun
    Feng, Ting T.
    Han, Ju G.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2014, 32 (08): : 1231 - 1247
  • [3] Crystal Structure of the Cystic Fibrosis Transmembrane Conductance Regulator Inhibitory Factor Cif Reveals Novel Active-Site Features of an Epoxide Hydrolase Virulence Factor
    Bahl, Christopher D.
    Morisseau, Christophe
    Bomberger, Jennifer M.
    Stanton, Bruce A.
    Hammock, Bruce D.
    O'Toole, George A.
    Madden, Dean R.
    JOURNAL OF BACTERIOLOGY, 2010, 192 (07) : 1785 - 1795
  • [4] Crystal structure of X-prolyl aminopeptidase from Caenorhabditis elegans: A cytosolic enzyme with a di-nuclear active site
    Iyer, Shalini
    La-Borde, Penelope J.
    Payne, Karl A. P.
    Parsons, Mark R.
    Turner, Anthony J.
    Isaac, R. Elwyn
    Acharya, K. Ravi
    FEBS OPEN BIO, 2015, 5 : 292 - 302
  • [5] Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions
    Tomek, Petr
    Palmer, Brian D.
    Flanagan, Jack U.
    Sun, Chuanwen
    Raven, Emma L.
    Ching, Lai-Ming
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 126 : 983 - 996
  • [6] 2-amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (β-site APP cleaving enzyme):: Use of structure based design to convert a micromolar hit into a nanomolar lead
    Baxter, Ellen W.
    Conway, Kelly A.
    Kennis, Ludo
    Bischoff, Francois
    Mercken, Marc H.
    De Winter, Hans L.
    Reynolds, Charles H.
    Tounge, Brett A.
    Luo, Chi
    Scott, Malcolm K.
    Huang, Yifang
    Braeken, Mirielle
    Pieters, Sere M. A.
    Berthelot, Didier J. C.
    Masure, Stefan
    Bruinzeel, Wouter D.
    Jordan, Alfonzo D.
    Parker, Michael H.
    Boyd, Robert E.
    Qu, Junya
    Alexander, Richard S.
    Brenneman, Douglas E.
    Reitz, Allen B.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) : 4261 - 4264
  • [7] Investigation by site-directed mutagenesis of the role of cytochrome P450 2B4 non-active-site residues in protein-ligand interactions based on crystal structures of the ligand-bound enzyme
    Wilderman, P. Ross
    Gay, Sean C.
    Jang, Hyun-Hee
    Zhang, Qinghai
    Stout, C. David
    Halpert, James R.
    FEBS JOURNAL, 2012, 279 (09) : 1607 - 1620